NDC 60717-920-25 - Dermisa Skin Fade Cream
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60717-920
- Requested NDC
- 60717-920-25
- Package NDCs from labels
- 60717-920-50, 60717-920-25
- Manufacturer
- RNA PHARMA, LLC
- Effective date
- 2019-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dermisa Skin Fade Cream - RNA PHARMA, LLC | RNA PHARMA, LLC | 2019-12-18 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 60717-920-25 | 2021-12-22 | 99ee590c-2263-4cbb-e053-2995a90a5cd0 |
| 60717-920-50 | 2021-12-22 | 99ee590c-2263-4cbb-e053-2995a90a5cd0 |
| 60717-920-25 | 2021-01-29 | 99ee590c-2263-4cbb-e053-2995a90a5cd0 |
| 60717-920-50 | 2021-01-29 | 99ee590c-2263-4cbb-e053-2995a90a5cd0 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cle de peau BEAUTE PORE-REFINING MATTIFYING VEIL | AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE | Shiseido Americas Corporation | 270ecc83-4262-4102-a753-2acaf11360a0 | 2026-02-04 | Warnings | 4Y5P7MUD51 |
| Petroleum | WHITE PETROLATUM | Harris Teeter | de380df6-cc6e-4b2a-98de-fc08eeb6e8ea | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Harris Teeter | MINERAL | Harris Teeter | 401e3a7e-54be-47cc-88c3-a343f5cbbd10 | 2026-02-04 | Warnings, Adverse reactions | T5L8T28FGP |
| Petroleum | WHITE PETROLATUM | Hy-Vee, Inc. | 45867f42-9562-c111-e063-6394a90adb70 | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Major Pharmaceuticals | 0e7e11c5-a1f8-43c4-b8a6-211491052404 | 2026-02-04 | Warnings, Adverse reactions | 4T6H12BN9U |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Sportpharm LLC | 88e3624d-b8bb-4e65-9250-4c51d2bbed16 | 2026-02-03 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Comforts Petroleum Jelly | WHITE PETROLATUM | KROGER | 3feb3638-1cdc-62d4-e063-6294a90a1d89 | 2026-02-03 | Warnings | 4T6H12BN9U |
| Petroleum Skin Protectant | WHITE PETROLATUM | Demoulas Super Markets, Inc | 702215f0-4cfd-4a23-b47a-da691c136634 | 2026-02-03 | Warnings, Adverse reactions | 4T6H12BN9U |
| Vitamin A D | LANOLIN, PETROLATUM | Kroger Co. | b4aa9b58-d95e-4dac-9a34-213482e8ca34 | 2026-02-02 | Warnings, Adverse reactions | 4T6H12BN9U |
| Dr. C. Tuna Sun Stick SPF 50 | AVOBENZONE, OCTINOXATE, HOMOSALATE, OCTOCRYLENE | Farmasi US LLC | 49dc6040-b400-7f5b-e063-6394a90ac7d7 | 2026-02-02 | Warnings | 4Y5P7MUD51 |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-01-31 | Warnings | 4T6H12BN9U |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Lanolin, Petrolatum | LANOLIN, PETROLATUM | Rite Aid Corporation | 1b6d7cdf-e7bc-4fd4-939c-5eb0eaa1744d | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Pure petroleum | WHITE PETROLATUM | Rite Aid Corporation | f67be4cc-9983-4758-93c8-383919ec07ca | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| Advanced Healing | PETROLATUM | Rite Aid Corporation | 0d535736-ba61-42eb-9112-c154295372a2 | 2026-01-30 | Warnings, Adverse reactions | 4T6H12BN9U |
| ALOE UP SPORT NATURAL BALM SPF-15 | AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE | Aloe Care International, LLC | 3de029ed-97f7-4cb3-a32e-d412bf3b5874 | 2026-01-30 | Warnings | 4Y5P7MUD51 |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.